← FDA Drug Approvals (Drugs@FDA)
REVERSOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ORGANON USA INC · Approved 1988-05-13
Drug application
- FDA Application #
ANDA089624- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- REVERSOL
- Generic name
- Edrophonium Chloride
- Active ingredients
- EDROPHONIUM CHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- ORGANON USA INC
- First approval
- 1988-05-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown